NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/09/2022
Back to search
Official data from USPTO
HETLIOZ (TASIMELTEON) CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/09/2022
Trademark type
Combined
Nice classes
5
Filing date
03/03/2020
Registration date
08/09/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/09/2022
Last transaction
08/09/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2020
First use in commerce
12/01/2020
Drawing code
3
Owner type
03
Owner location
Washington, DC
Examiner
FOSTER, ALEXANDRA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Hetlioz" on a first line, and "(tasimelteon) capsules" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.
Holders and representatives
Holders
Vanda Pharmaceuticals Inc.
Representatives
Jayme M. Torelli HOFFMAN WARNICK LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationscontaining tasimelteonfor use in the treatment of Smith-Magenis Syndrome; Pharmaceutical preparationscontaining tasimelteonfor use in the treatment of sleep disorders
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/07/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/06/2022
DOCK
ASSIGNED TO EXAMINER
06/09/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/21/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/21/2022
IUAF
USE AMENDMENT FILED
04/11/2022
EISU
TEAS STATEMENT OF USE RECEIVED
04/11/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2021
PUBO
PUBLISHED FOR OPPOSITION
08/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/22/2021
GNFR
FINAL REFUSAL E-MAILED
02/22/2021
CNFR
FINAL REFUSAL WRITTEN
02/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2021
ALIE
ASSIGNED TO LIE
01/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/26/2020
GNRT
NON-FINAL ACTION E-MAILED
05/26/2020
CNRT
NON-FINAL ACTION WRITTEN
05/26/2020
DOCK
ASSIGNED TO EXAMINER
05/21/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2020
NWAP
NEW APPLICATION ENTERED
03/06/2020
Continuous trademark protection
Get notified about every new filing that threatens HETLIOZ (TASIMELTEON) CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.